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Determination of the appropriate conditions for protein crystallization remains
a highly empirical process. Preventing protein aggregation is necessary for
the formation of single crystals under aggregation-prone solution conditions.
Because many amino acids and amino acid derivatives offer a unique
combination of solubility and stabilizing properties, they open new avenues
into the ﬁeld of protein aggregation research. The use of amino acids and amino
acid derivatives can potentially inﬂuence processes such as heat treatment and
refolding reactions. The effect of the addition of several amino acids, such as
lysine, and several amino acid derivatives, such as glycine ethyl ester and glycine
amide, on the crystallization of equine hemoglobin and bovine pancreatic
ribonuclease A has been examined. The addition of these amino acids and
amino acid derivatives expanded the range of precipitant concentration in which
crystals formed without aggregation. The addition of such additives appears to
promote the crystallization of proteins.
Keywords: protein crystallization; promotion of crystallization; additives; amino acids;
amino acid derivatives; protein aggregation.
1. Introduction
Protein crystallography is of increasing importance for biological
research. The rapid determination of protein structures has been
achieved by progress in areas such as genetics, puriﬁcation techni-
ques, detector technology and synchrotron radiation. Crystallography
requires single crystals of high quality; however, an efﬁcient method
of obtaining these crystals has been difﬁcult to determine. This
difﬁculty depends on a huge number of parameters that inﬂuence
protein crystallization, which include protein concentration, pH, ionic
strength, type and concentration of precipitant, and the additives in
the crystallization solution (McPherson, 1999).
During crystallization, proteins often aggregate and do not crys-
tallize. Various studies by dynamic light scattering have shown that
crystal nucleation is generally characterized by a relatively sharp
transition from a monodisperse solution to insolubility with
increasing precipitant concentration, whereas a continuum of
aggregates before precipitation leads to the formation of a predo-
minantly amorphous material (Mikol et al., 1990). Therefore, the
prevention of nonspeciﬁc protein aggregation plays a key role in the
formation of nuclei and/or single crystals under aggregation-prone
solution conditions. In some cases, aggregation can be eliminated by
imposing a reasonably high ionic strength to disrupt the electrostatic
interactions that cause some molecules to aggregate. Guanidine and
urea are well known aggregation suppressors that minimize the
hydrophobic intermolecular interaction between proteins. These
denaturants increase the solubility of unfolded protein molecules
(Buchner & Rudolph, 1991; Rudolph & Lilie, 1996). They are often
used as additives for the initial screening, but can decrease the
stability of the native state of proteins.
Recently, amino acids, such as arginine, and amino acid derivatives,
such as glycine ethyl ester (GlyEE), which are non-denaturating
reagents, have been widely used in biochemical studies to increase
refolding yields by decreasing aggregation and to increase protein
stability (Shiraki et al., 2002, 2004, 2005; Arakawa & Tsumoto, 2003;
Taneja & Ahmad, 1994; Sakamoto et al., 2004). It is also expected that
these non-denaturating reagents will suppress nonspeciﬁc aggrega-
tion in supersaturated protein solutions during the crystallization
process. We have observed the beneﬁcial effect of the addition of
these reagents on the crystallization of hen egg-white lysozyme (in
preparation). The results showed that the additives expanded the
crystallization conditions, such as protein concentration, the types of
precipitant and the precipitant concentration. In the study reported
here, we investigated the effect of the addition of amino acids and
amino acid derivatives on the crystallization of two new proteins:
equine hemoglobin and bovine pancreatic ribonuclease A. As in the
lysozyme study, crystals of both proteins readily formed in an
expanded concentration range of known precipitants. The results
suggest that the addition of these reagents is generally effective in
promoting the crystallization of many types of proteins.
2. Materials and methods
2.1. Reagents
l-Lysine/HCl, GlyEE/HCl and aspartic acid/NaOH were
purchased from Sigma–Aldrich Co. (St Louis, MO, USA). The other
amino acids, amino acid derivatives and other chemicals were
purchased from Wako Pure Chemical Industries (Osaka, Japan). Allchemicals used were of high-quality analytical grade. Equine hemo-
globin was purchased from Sigma–Aldrich Co. Bovine pancreatic
ribonuclease A was purchased from Worthington Biochemical Co.
(California, USA). All proteins were used without further puriﬁca-
tion. Hemoglobin and ribonuclease A were crystallized with PEG
3350 (McPherson, 1999) and with ammonium sulfate (Chatani et al.,
2002) as a precipitant, respectively.
2.2. Characterization of the effects for crystallization
We prepared solutions containing 40 mg ml
1 of hemoglobin in
0.1 M sodium phosphate at pH 6.5, and 28.4 mg ml
1 ribonuclease A
in 0.1 M sodium acetate at pH 6.0. All protein solutions were
centrifuged at 15000g for 20 min at 293 K. For hemoglobin crystal-
lization, we prepared a reservoir solution containing 5.0–40.0%
(approximately saturated solution) PEG 3350 at 2.5% intervals,
0.2 M additives and 0.1 M sodium phosphate (pH 6.5). For ribo-
nuclease A crystallization, we prepared a reservoir solution
containing 35% ammonium sulfate, 0.5 M additives and 0.1 M sodium
acetate (pH 6.0). The hanging-drop vapor-diffusion method was used
for crystallization at 293 K. Hanging droplets were made by mixing
1 ml of protein solution with 1 ml of reservoir solution containing
additives. Thus, the initial concentration of the additives in each
hanging droplet was 0.1 and 0.25 M, respectively. The volume of
reservoir solution was 500 ml for each setting. In all the crystallization
experiments, reproducibility was evaluated by repeating each
experiment more than three times.
3. Results and discussion
Fig. 1 shows the results of crystallization of hemoglobin in the
presence of additives with an initial concentration of 0.1 M in the
hanging droplet at pH 6.5. The control experiment showed that
hemoglobin crystals were obtained in the range 15.0–35.0%(w/v)o f
PEG 3350 in the absence of additives. In contrast, the concentration
conditions of precipitant expanded in many cases in the presence of
the additives. The use of Glu, Arg and glycine amide (GlyAmd) as
additives was most effective for the expansion of the conditions of the
precipitant concentration. When the concentration exceeded the
precipitant by more than 37.5%, the hemoglobin solution aggregated
in the absence of any additives, whereas single crystals appeared in
the presence of Lys, Arg and GlyAmd, even at 40% of PEG 3350. In
the presence of Gly, Glu and Lys–Glu, the concentration range in
which crystals were obtained was expanded to a lower concentration.
All the crystals had similar morphologies. In addition, the crystals
formed more rapidly in the presence of the additives.
For ribonuclease A, no crystals formed and aggregations occurred
under all concentration conditions of the precipitant in the absence of
additives (Fig. 2), even though previously reported crystallization
conditions were used. Difﬁculties associated with the crystallization
could have been attributable to the different properties of each
protein depending on the preparation and the commercial sample
batch. In this experiment, ribonuclease A crystals were grown only
from the conditions containing 0.25 M Asp or GlyEE (Fig. 2) in the
droplet, suggesting that the presence of an appropriate additive
suppresses the nonspeciﬁc aggregation and raises the probability of
obtaining crystals.
The presence of an amino acid or an amino acid derivative
suppresses aggregation by hydrophobic interaction between de-
natured proteins. In a supersaturated solution of proteins in their
native state and precipitant, it is considered that this should control
hydrophobic interactions between the protein surfaces and suppress
nonspeciﬁc aggregation. Additionally, the additives shield charges of
the various functional groups on the protein surface and weaken the
interaction between charged amino acid residues (Arakawa et al.,
2007). This should also make it possible to precipitate gently under
high-concentration crystallization conditions. Amidation and ester-
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Figure 1
Concentration range of precipitant in the reservoir solution in the presence of
additives in which hemoglobin crystals were formed. Hanging droplets were made
by mixing 1 mlo f4 0m gm l
1 hemoglobin solution with 1 ml of reservoir solution.
The reservoir solutions contain 5.0–40.0% PEG 3350 at 2.5% intervals, 0.2 M
additives and 0.1 M sodium phosphate (pH 6.5). The bars show the precipitant
concentration range in which crystals were formed.
Figure 2
Results of the crystallization of ribonuclease A with and without the addition of
Asp and GlyEE. Hanging droplets were made by mixing 1 ml of 28.4 mg ml
1
ribonuclease A solution with 1 ml of reservoir solution. The reservoir solutions
contain 35% ammonium sulfate, 0.5 M additives and 0.1 M sodium acetate (pH
6.0).iﬁcation of the carboxyl group in Gly change the electrostatic char-
acter and the hydrophobicity of the amino acid and change the ability
to form hydrophobic and electrostatic interactions. Choosing the
appropriate additives is necessary for controlling hydrophobic and
electrostatic interaction between protein molecules.
Spontaneous nucleation of protein crystals generally occurs in a
highly supersaturated solution and the nuclei cannot be generated in
a less supersaturated solution. However, our results using hemo-
globin showed that many crystals appeared in a less supersaturated
solution condition in the presence of an amino acid or an amino acid
derivative. These results suggest that these additives decrease the
solubility of hemoglobin and act as a precipitant. It is interesting that
Glu, Arg and GlyAmd expand the conditions for both lower and
higher concentrations, and they suppress nonspeciﬁc precipitation
while promoting ordered precipitation.
4. Conclusion
We examined the effect of various additives on protein crystallization
for two proteins. We found that some amino acids and amino acid
derivatives generally promote protein crystallization. Further studies
should address the mechanism of crystallization in the presence of
such additives and optimize conditions to apply this method more
generally and speciﬁcally on protein crystallization. Creating ordered
crystallization of proteins should be more easily achieved in the
future by choosing an additive based on the properties of the protein.
We appreciate Dr Hiroshi Komatsu for useful discussions. We
thank Ms Satomi Uramoto for performing many of the crystallization
experiments.
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